TBPH Next Earnings Date Notes

— Theravance Biopharma (TBPH) is a biopharmaceutical company focused on discovering, developing, & commercializing organ-selective medicines that address unmet medical needs, particularly in the areas of respiratory & infectious diseases. The company's primary commercial asset is YUPELRI® (revefenacin) inhalation solution, used in the treatment of chronic obstructive pulmonary disease (COPD), which generates royalty revenue for TBPH. In addition, Theravance is advancing a pipeline of investigational drugs, but its near-term financials largely depend on YUPELRI royalties & the effective management of expenses as it optimizes costs post-restructuring. For long-term performance, investors should pay close attention to: quarterly YUPELRI sales & royalty revenues (including net sales trend data), partnered pipeline progress updates (notably clinical milestones or new collaborations), operating expenses (R&D and SG&A), and the company's cash runway. Listening for management's commentary on strategic priorities, royalty guidance, cost savings, and any updates on pipeline development—especially new data or partnering activity—will offer critical insight into the sustainability & growth potential of the business model. The next projected earnings date for TBPH is 3/24/2026 after close (stay tuned for a confirmed earnings date once announced).

TBPH Next Earnings Date FAQ

On this page we presented the TBPH Next Earnings Date information for Theravance Biopharma along with recent past earnings dates. For Q3 of 2025, TBPH reported earnings of 0.070/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, TBPH reported earnings of -0.080/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, TBPH reported earnings of -0.270/share, with the earnings report taking place on 5/8/2025. For Q4 of 2024, TBPH reported earnings of -0.050/share, with the earnings report taking place on 2/26/2025. For Q3 of 2024, TBPH reported earnings of -0.060/share, with the earnings report taking place on 11/12/2024. Based on these past earnings dates, the projected next earnings date for TBPH is 3/24/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Theravance Biopharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Theravance Biopharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Theravance Biopharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next TBPH earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up TBPH's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the TBPH next earnings date.